Clinical trial

Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex…

NCT00111397 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00111397
Title Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection
Official title A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex and Other Pulmonary Nontuberculous Mycobacterial Infections
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Mycobacterium Avium-Intracellulare Infection
Intervention type Drug, Procedure
Interventions Cytokine therapy, Interferon Gamma, GM-CSF
Enrollment 2
Start date May 13, 2005
Primary completion Aug 4, 2010
Completion Aug 4, 2010
First posted May 20, 2005
Last update posted Jul 2, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies